WFW advises MSC Cruises on €353m ECA-backed financing of PortMiami mega cruise terminal
Construction is expected to be completed in December 2023 and, when finished, will be the largest cruise terminal in the US.
Press Archive
WFW advises ING on US$40m sustainability-linked loan with BW LPG for four VLGCs
The amendments aimed at incorporating sustainability linked provisions into the facility, highlighting the conscious effort of all parties involved to support and recognise the importance of ESG in maritime facilities.
WFW advises on LEFGL French pilot floating offshore wind farm financing and due diligence
The project is being developed by OW, a joint venture between Engie and EDP Renewables.
WFW secures victory for Abbey Healthcare in key Court of Appeal ruling
In an important decision, the Court of Appeal overturned a High Court judgment that had restricted the use of a quicker and cheaper means of resolving construction disputes.
WFW advises on Eolmed French pilot floating offshore wind farm financing
This is one of the first four pilot floating offshore wind farms under development in France.
WFW advises clients on NAC Chapter 11 restructuring
NAC is the largest lessor of regional aircraft, with over 500 aircraft. Since the onset of the pandemic, NAC is to-date the only aircraft lessor to have entered into any formal restructuring proceedings.
WFW advises Greenalia on 183 MW PPA with Alcoa
Under the PPA, the power supply is expected to commence in 2024 and run until the end of 2033.
WFW advises VORTEX on acquisition of Achab
WFW advised Vortex on all due diligence related matters, including real estate, employment, competition and tax matters.
WFW advises Snam on US$350m acquisition of Golar Tundra
The Golar Tundra will contribute circa 6.5% of Italy’s gas needs, bringing the Italian regasification capacity to more than 25% of demand.
WFW advises Rigenerand minority shareholders on sale to Evotec
Founded as a spin-off of the University of Modena and Reggio Emilia in 2009, Rigenerand is a pioneering company in the field of advanced stem cell-based cancer therapies.
